Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs

The behaviour of active (AR) and inactive (IR) renin was studied in 48 hypertensive patients (37 with uncomplicated essential hypertension and 11 with reno-vascular hypertension) treated with indomethacin alone or with AR stimulating (bumetanide, tienilic acid, captopril) and inhibiting (atenolol) d...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental hypertension. Part A, Theory and practice Vol. 4; no. 11-12; p. 2435
Main Authors Salvetti, A, Pedrinelli, R, Sassano, P, Arzilli, F, Turini, F
Format Journal Article
LanguageEnglish
Published United States 1982
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The behaviour of active (AR) and inactive (IR) renin was studied in 48 hypertensive patients (37 with uncomplicated essential hypertension and 11 with reno-vascular hypertension) treated with indomethacin alone or with AR stimulating (bumetanide, tienilic acid, captopril) and inhibiting (atenolol) drugs before and after indomethacin addition. In 10 pts indomethacin (50mg q.i.d./3 days) reduced (p less than 0.05) AR and to a lesser extent IR. In 6 pts bumetanide (1 mg) increased (p less than 0.05) only AR and this effect was abolished by indomethacin. In 6 pts tienilic acid (250 mg) increased (p less than 0.05) only AR and this action was unchanged by indomethacin. In 11 renovascular pts captopril (100mg) increased AR (p less than 0.01) and lesser IR and both these effects were uninfluenced by indomethacin. In 11 essential hypertensive pts captopril (25mg b.i.d./3 days) increased only AR (p less than 0.02), but after 1 year both AR and IR were increased (p less than 0.05) and these effects were abolished by indomethacin. In all the above reported protocols we did never find any inverse correlation between either AR and IR values or their induced changes. These data suggest that prostaglandins stimulate, even if not to a similar extent, both AR and IR and that drugs, which stimulate renin either through or independently of PGs, did not cause any apparent interconversion of plasma IR into AR. In 6 pts atenolol (100 mg daily/6 days) reduced AR (p less than 0.05) and tended to increase IR. Indomethacin addition further decreased AR and reduced IR (both p less than 0.05 vs atenolol alone): however the proportion (% of total) of IR was still reduced. These findings suggest that beta 1-adrenoreceptors blockade exerts a divergent effect on active and inactive renin and that this action is not influenced by PGs synthesis inhibition.
AbstractList The behaviour of active (AR) and inactive (IR) renin was studied in 48 hypertensive patients (37 with uncomplicated essential hypertension and 11 with reno-vascular hypertension) treated with indomethacin alone or with AR stimulating (bumetanide, tienilic acid, captopril) and inhibiting (atenolol) drugs before and after indomethacin addition. In 10 pts indomethacin (50mg q.i.d./3 days) reduced (p less than 0.05) AR and to a lesser extent IR. In 6 pts bumetanide (1 mg) increased (p less than 0.05) only AR and this effect was abolished by indomethacin. In 6 pts tienilic acid (250 mg) increased (p less than 0.05) only AR and this action was unchanged by indomethacin. In 11 renovascular pts captopril (100mg) increased AR (p less than 0.01) and lesser IR and both these effects were uninfluenced by indomethacin. In 11 essential hypertensive pts captopril (25mg b.i.d./3 days) increased only AR (p less than 0.02), but after 1 year both AR and IR were increased (p less than 0.05) and these effects were abolished by indomethacin. In all the above reported protocols we did never find any inverse correlation between either AR and IR values or their induced changes. These data suggest that prostaglandins stimulate, even if not to a similar extent, both AR and IR and that drugs, which stimulate renin either through or independently of PGs, did not cause any apparent interconversion of plasma IR into AR. In 6 pts atenolol (100 mg daily/6 days) reduced AR (p less than 0.05) and tended to increase IR. Indomethacin addition further decreased AR and reduced IR (both p less than 0.05 vs atenolol alone): however the proportion (% of total) of IR was still reduced. These findings suggest that beta 1-adrenoreceptors blockade exerts a divergent effect on active and inactive renin and that this action is not influenced by PGs synthesis inhibition.
Author Sassano, P
Turini, F
Pedrinelli, R
Arzilli, F
Salvetti, A
Author_xml – sequence: 1
  givenname: A
  surname: Salvetti
  fullname: Salvetti, A
– sequence: 2
  givenname: R
  surname: Pedrinelli
  fullname: Pedrinelli, R
– sequence: 3
  givenname: P
  surname: Sassano
  fullname: Sassano, P
– sequence: 4
  givenname: F
  surname: Arzilli
  fullname: Arzilli, F
– sequence: 5
  givenname: F
  surname: Turini
  fullname: Turini, F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6756707$$D View this record in MEDLINE/PubMed
BookMark eNotj81qwzAQhHVISZO0D9BDQS_gdqXIkn0sIf2BQC_tOehnZasksrGUQt6-Cg0sLLPfMMwuySwOEQl5YPC0ZtA-M5CCtbLh0ILkAtiMLECtoQJQ6pYsU_oBkEqKZk7mUtVSgVqQuPUebU508HSchpR1d9DRhZhoiH0wIYch0jK217HDy5Vqm8Mv0mIr6iomjIWE6E4WHTXnQnPozyNOGWO6ONx06tIdufH6kPD-ulfk-3X7tXmvdp9vH5uXXWVL8VzV0GjeonRrCa7xjmnwBiQKXsvCLCoOqESNoLi3TAnfgEFvtXDGtcbwFXn8zx1P5ohuP07hqKfz_vo3_wO0r10G
CitedBy_id crossref_primary_10_1111_j_1365_2362_1985_tb00158_x
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.3109/10641968209062401
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 6756707
Genre Controlled Clinical Trial
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID .GJ
53G
5RE
AAORF
AAPXX
ABWCV
ABZEW
ACGFS
ADCVX
AFLEI
AI.
AJVHN
ALMA_UNASSIGNED_HOLDINGS
BLEHA
BRMBE
CGR
CUY
CVF
CYYVM
ECM
EIF
F5P
H13
JENTW
NPM
QQXMO
TDBHL
TFW
VH1
ZGI
ZXP
ID FETCH-LOGICAL-c401t-508a29e6d360d8fd1a0fb06e4256508ce720e745e072fc174f80befca4dbd9bb2
ISSN 0730-0077
IngestDate Sat Sep 28 07:33:48 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11-12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c401t-508a29e6d360d8fd1a0fb06e4256508ce720e745e072fc174f80befca4dbd9bb2
PMID 6756707
ParticipantIDs pubmed_primary_6756707
PublicationCentury 1900
PublicationDate 1982-00-00
PublicationDateYYYYMMDD 1982-01-01
PublicationDate_xml – year: 1982
  text: 1982-00-00
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical and experimental hypertension. Part A, Theory and practice
PublicationTitleAlternate Clin Exp Hypertens A
PublicationYear 1982
SSID ssj0067648
Score 1.2699791
Snippet The behaviour of active (AR) and inactive (IR) renin was studied in 48 hypertensive patients (37 with uncomplicated essential hypertension and 11 with...
SourceID pubmed
SourceType Index Database
StartPage 2435
SubjectTerms Adult
Atenolol - therapeutic use
Bumetanide - therapeutic use
Captopril - therapeutic use
Cold Temperature
Diuretics - therapeutic use
Enzyme Precursors - blood
Female
Glycolates - therapeutic use
Humans
Hypertension - drug therapy
Hypertension - enzymology
Hypertension, Renovascular - drug therapy
Hypertension, Renovascular - enzymology
Indomethacin - therapeutic use
Male
Middle Aged
Placebos
Proline - analogs & derivatives
Propanolamines - therapeutic use
Prostaglandins - physiology
Renin - blood
Ticrynafen - therapeutic use
Title Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs
URI https://www.ncbi.nlm.nih.gov/pubmed/6756707
Volume 4
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBablJZcQvoIfaXo0Ftx67VlyT4uJSEUkkNJILegJzGkzrLxFpr_1f_XkWZ27WwftIXFrCVZa2s-j2Zm58HYW9GoUJvKZdoLmwkrqqz2MQo4t6UqXClLEQOcT07l8bn4dFFdTCbfR15Ly968t3e_jCv5H6pCG9A1Rsn-A2XXk0IDfAf6whEoDMe_ovHh4Iwxj9EbOhXkaJNv-FVrWpQGO4ruTZ6vOvE3yrlEJ9HhLjo8uqVFeRRWu70CBXWxcm93iyXZ01dJDVYBlXGie1UChutgFUBAXfTvZuiJFJMAUF4CjMxaW3f09Vffo1_BbODVLgYmXmP49udh7O2tTuXCh8i02eKupXFHgxVj2tTFyIqBzA44TRZzC405sxgDcJqRvzVxWoFpTja3gBIzqIKmK4C5gHwTEzEL_KkRJOZfEiZAXZIKy-7-sXMjJzf1bLEtVUfmehpNRLj9SyVTybb1A-Ff6fG2Pvx0UzvsIU21odUk6eZsj-2SWsJniLHHbOK7J-zRCTlePGUdQY3fBH4fanyAGocPQQ1aOaKLwzC-ghpPUOMENW6-8U2o8QS1Z-z86PDs43FGpToyC4_RZyDm66LxEl7u3NXBTXUeTC497AhRBbBeFblXovK5KoIFLTjUufHBauGMa4wp9tl2d9P554wHGcpSCQvXQq-UjXPR6q1D1WgHJy_YPq7U5RzzsVzSEr78XccrtjNA7jV7EOD19wcgS_bmTaLdD5ekduc
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+prostaglandins+inhibition+on+changes+in+active+and+inactive+renin+induced+by+antihypertensive+drugs&rft.jtitle=Clinical+and+experimental+hypertension.+Part+A%2C+Theory+and+practice&rft.au=Salvetti%2C+A&rft.au=Pedrinelli%2C+R&rft.au=Sassano%2C+P&rft.au=Arzilli%2C+F&rft.date=1982-01-01&rft.issn=0730-0077&rft.volume=4&rft.issue=11-12&rft.spage=2435&rft_id=info:doi/10.3109%2F10641968209062401&rft_id=info%3Apmid%2F6756707&rft_id=info%3Apmid%2F6756707&rft.externalDocID=6756707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0730-0077&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0730-0077&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0730-0077&client=summon